Rankings
▼
Calendar
RGEN Q4 2024 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q4 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$168M
+7.6% YoY
Gross Profit
$39M
23.2% margin
Operating Income
-$37M
-21.8% margin
Net Income
-$34M
-20.2% margin
EPS (Diluted)
$-0.60
QoQ Revenue Growth
+8.2%
Cash Flow
Operating Cash Flow
$39M
Free Cash Flow
$32M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$2.8B
Total Liabilities
$857M
Stockholders' Equity
$2.0B
Cash & Equivalents
$757M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$168M
$156M
+7.6%
Gross Profit
$39M
$68M
-42.5%
Operating Income
-$37M
-$887,000
-4015.1%
Net Income
-$34M
-$25M
-32.9%
Revenue Segments
Product
$174M
100%
← FY 2024
All Quarters
Q1 2025 →